BioCentury
ARTICLE | Finance

Crossing D finish line

Investors back Avedro's corneal cross-linking system for U.S.

March 18, 2013 7:00 AM UTC

Avedro Inc. hopes its $43 million series D round will fund the launch of the first corneal cross-linking system in the U.S. The company expects an FDA decision on its NDA in 2H14.

New investor Abingworth led the round. New investor Third Point participated, along with existing investors Prism Venture Works; De Novo Ventures; Flagship Ventures; Aperture Ventures; SCP Vitalife Partners; Borealis Ventures; and Echelon Ventures...